Home > Balance Sheet > BAL PHARMA

BAL PHARMA
Total Non-Current Liabilities

    Back to Balance Sheet
COMMUNITY POLL
for BAL PHARMA
Please provide your vote to see the results

BAL PHARMA Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Total Non-Current Liabilities ₹45 Cr₹38 Cr₹36 Cr₹34 Cr₹34 Cr

What is the latest Total Non-Current Liabilities ratio of BAL PHARMA ?

The latest Total Non-Current Liabilities ratio of BAL PHARMA is ₹45 Cr based on Mar2024 Consolidated results.
Year Total Non-Current Liabilities
Mar2024₹45 Cr
Mar2023₹38 Cr
Mar2022₹36 Cr
Mar2021₹34 Cr
Mar2020₹34 Cr

How is Total Non-Current Liabilities of BAL PHARMA Trending?

Years Total Non-Current Liabilities % Change
Mar2024 ₹45 Cr
18.02
Mar2023 ₹38 Cr
4.32
Mar2022 ₹36 Cr
6.44
Mar2021 ₹34 Cr
1.87
Mar2020 ₹34 Cr -

Compare Total Non-Current Liabilities of peers of BAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAL PHARMA ₹140.8 Cr -6% -10.8% -22.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹394,115.0 Cr 3.5% -3.4% -5.8% Stock Analytics
DIVIS LABORATORIES ₹162,735.0 Cr 3.7% -10.2% 25.6% Stock Analytics
CIPLA ₹126,313.0 Cr 5.3% 6.1% -1.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹122,592.0 Cr 1.4% 4.6% 7.6% Stock Analytics
DR REDDYS LABORATORIES ₹105,095.0 Cr 3.9% 0% -9.9% Stock Analytics


BAL PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BAL PHARMA

-6%

-10.8%

-22.7%

SENSEX

-0%

-2.4%

1.2%


You may also like the below Video Courses